MCID: PRN021
MIFTS: 48

Paranasal Sinus Disease

Categories: Respiratory diseases

Aliases & Classifications for Paranasal Sinus Disease

MalaCards integrated aliases for Paranasal Sinus Disease:

Name: Paranasal Sinus Disease 12 14
Paranasal Sinus Diseases 42 69
Disorder of Nasal Sinus 12

Classifications:



External Ids:

Disease Ontology 12 DOID:1352
MeSH 42 D010254
NCIt 47 C26843
SNOMED-CT 64 195823002 7393007
UMLS 69 C0030469

Summaries for Paranasal Sinus Disease

MalaCards based summary : Paranasal Sinus Disease, also known as paranasal sinus diseases, is related to asthma and myoclonic astatic epilepsy. An important gene associated with Paranasal Sinus Disease is IL5 (Interleukin 5), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Amoxicillin and Cefditoren have been mentioned in the context of this disorder. Affiliated tissues include heart, bone and eye, and related phenotypes are hematopoietic system and homeostasis/metabolism

Wikipedia : 72 Paranasal sinuses are a group of four paired air-filled spaces that surround the nasal cavity. The... more...

Related Diseases for Paranasal Sinus Disease

Diseases related to Paranasal Sinus Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 193)
id Related Disease Score Top Affiliating Genes
1 asthma 27.6 ALOX5 CD79A GATA3 IFNG IL10 IL13
2 myoclonic astatic epilepsy 10.8 IFNG IL4
3 cytoplasmic body myopathy 10.8 IL13 IL5
4 gastroschisis 10.8 IFNG IL5
5 acute ackee fruit intoxication 10.8 IL10 IL4
6 aortic arch interruption 10.8 IL13 IL5
7 cystadenocarcinoma 10.7 IL10 IL13
8 basidiobolomycosis 10.7 IL10 IL4
9 hypercementosis 10.7 IL13 IL5
10 lagophthalmos 10.7 IL10 IL4
11 winchester syndrome 10.7 IL13 IL4 IL5
12 purpura fulminans 10.7 IL13 IL4 IL5
13 x-linked intellectual disability, van esch type 10.7 IFNG IL4 IL5
14 fungal gastritis 10.7 IL13 IL4 IL5
15 abdominal tuberculosis 10.7 IL13 IL4 IL5
16 indian tick typhus 10.7 IFNG IL13
17 trachea leiomyoma 10.7 IL13 IL4 IL5
18 glucose intolerance 10.7 IL13 IL4 IL5
19 viljoen kallis voges syndrome 10.7 IL13 IL4 IL5
20 hypothyroidism due to deficient transcription factors involved in pituitary development or function 10.7 IFNG IL4 IL5
21 goat milk allergy 10.7 IFNG IL13 IL4
22 fibrous histiocytoma 10.7 IFNG IL4 IL5
23 eye accommodation disease 10.7 IFNG IL10 IL4
24 leukocyte disease 10.7 IL13 IL4 IL5
25 thelaziasis 10.7 IFNG IL10 IL4
26 cow milk allergy 10.7 IL10 IL13 IL4
27 inflamed seborrheic keratosis 10.6 IL13 IL4 IL5
28 centronuclear myopathy 5 10.6 IFNG IL10 IL4
29 graft-versus-host disease, protection against 10.6 IFNG IL10
30 multiple congenital anomalies mental retardation, growth failure and cleft lip palate 10.6 IFNG IL10 IL5
31 dentin caries 10.6 IL13 IL4 IL5
32 acute necrotizing encephalopathy type 1 10.6 IFNG IL13 IL5
33 benign mammary dysplasia 10.6 IL13 IL4 IL5
34 spindle cell hemangioma 10.6 IFNG IL10 IL4
35 early-onset zonular cataract 10.6 IFNG IL10 IL4
36 papillary squamous carcinoma 10.6 IFNG IL10 IL13
37 neutrophil-specific granule deficiency 10.6 IL10 IL17A
38 legionnaires' disease 10.6 PLAU PLAUR
39 primary microcephaly-mild intellectual disability-young-onset diabetes syndrome 10.6 IL10 TGFB1
40 acute monoblastic leukemia 10.6 IFNG IL10 IL4
41 deafness, autosomal recessive 22 10.6 IL10 IL4
42 colon adenocarcinoma 10.6 IL10 IL4 IL5
43 malignant hyperthermia 10.6 IFNG IL4 IL5
44 toxic diffuse goiter 10.6 IL13 IL5
45 esophagus melanoma 10.6 IFNG IL10 IL4
46 gastric ulcer 10.6 IFNG IL10 IL5
47 marasmus 10.6 IL4 IL5
48 primary systemic mycosis 10.5 IFNG IL17A
49 mucocutaneous leishmaniasis 10.5 IFNG IL10 IL4
50 blue toe syndrome 10.5 IFNG IL10 IL4

Graphical network of the top 20 diseases related to Paranasal Sinus Disease:



Diseases related to Paranasal Sinus Disease

Symptoms & Phenotypes for Paranasal Sinus Disease

MGI Mouse Phenotypes related to Paranasal Sinus Disease:

44 (show all 19)
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.37 CD79A IFNG GATA3 ALOX5 TGFB1 IL10
2 homeostasis/metabolism MP:0005376 10.36 CD79A IFNG GATA3 ALOX5 TGFB1 IL10
3 growth/size/body region MP:0005378 10.35 IFNG FLNC GATA3 TGFB1 IL10 IL17A
4 immune system MP:0005387 10.34 CD79A IFNG GATA3 ALOX5 TGFB1 IL10
5 cellular MP:0005384 10.32 CD79A IFNG GATA3 ALOX5 TGFB1 IL10
6 cardiovascular system MP:0005385 10.24 FLNC IFNG GATA3 ALOX5 TGFB1 IL10
7 digestive/alimentary MP:0005381 10.21 IFNG GATA3 TGFB1 IL10 IL17A IL4
8 mortality/aging MP:0010768 10.17 GATA3 FLNC IFNG TGFB1 IL13 IL17A
9 endocrine/exocrine gland MP:0005379 10.15 IFNG GATA3 TGFB1 IL13 IL17A IL10
10 craniofacial MP:0005382 10.11 IFNG GATA3 TGFB1 IL10 IL17A IL4
11 liver/biliary system MP:0005370 10.11 CD79A IFNG TGFB1 IL10 IL4 IL5
12 integument MP:0010771 10.08 FLNC IFNG GATA3 TGFB1 IL13 IL10
13 muscle MP:0005369 10.01 FLNC IFNG GATA3 TGFB1 IL10 IL13
14 neoplasm MP:0002006 9.91 CD79A IFNG TGFB1 IL10 PLAU IL5
15 no phenotypic analysis MP:0003012 9.87 CD79A IFNG GATA3 IL4 IL13 IL17A
16 renal/urinary system MP:0005367 9.86 CD79A IFNG GATA3 TGFB1 IL17A IL4
17 reproductive system MP:0005389 9.76 IFNG GATA3 TGFB1 IL13 IL10 IL4
18 respiratory system MP:0005388 9.73 IFNG FLNC IL10 TGFB1 IL17A IL4
19 skeleton MP:0005390 9.28 IFNG GATA3 ALOX5 TGFB1 IL10 IL17A

Drugs & Therapeutics for Paranasal Sinus Disease

Drugs for Paranasal Sinus Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 539)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 2 26787-78-0 33613 2171
2
Cefditoren Approved Phase 4 117467-28-4, 104145-95-1 9571074 9870843
3
Montelukast Approved Phase 4 158966-92-8 5281040
4
Desflurane Approved Phase 4 57041-67-5 42113
5
Dexmedetomidine Approved, Vet_approved Phase 4 76631-46-4, 113775-47-6 68602 5311068 56032
6
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2 51-43-4 5816
7
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
8 Racepinephrine Approved Phase 4,Phase 3,Phase 2
9
Remifentanil Approved Phase 4 132875-61-7 60815
10
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
11
Metoprolol Approved, Investigational Phase 4 37350-58-6, 51384-51-1 4171
12
Tramadol Approved, Investigational Phase 4 27203-92-5 33741
13
Amiodarone Approved, Investigational Phase 4,Phase 3,Phase 2 1951-25-3 2157
14
Benzocaine Approved Phase 4,Phase 3,Phase 1,Phase 2 1994-09-7, 94-09-7 2337
15
Menthol Approved Phase 4,Phase 3,Phase 2,Phase 1 2216-51-5 16666
16
Digoxin Approved Phase 4 20830-75-5 30322 2724385
17
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 53-03-2 5865
18
Oxymetazoline Approved Phase 4 1491-59-4 4636
19
Phenylephrine Approved Phase 4 59-42-7 6041
20
Budesonide Approved Phase 4,Phase 2,Phase 3,Phase 1 51333-22-3 63006 5281004
21
Acetaminophen Approved Phase 4,Phase 2,Phase 3 103-90-2 1983
22
Dextromethorphan Approved Phase 4 125-71-3 5360696 5362449
23
Ephedrine Approved Phase 4,Phase 2,Phase 1 299-42-3 9294
24
Guaifenesin Approved, Vet_approved Phase 4,Phase 2 93-14-1 3516
25
Pseudoephedrine Approved Phase 4,Phase 2,Phase 1 90-82-4 7028
26
Hyaluronic acid Approved, Vet_approved Phase 4 9004-61-9 53477741 24759
27
Cocaine Approved, Illicit Phase 4,Phase 3 50-36-2 5760 446220
28
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-61-6, 62-31-7 681
29
Thrombin Approved Phase 4
30
Triamcinolone Approved, Vet_approved Phase 4,Phase 3 124-94-7 31307
31
Azithromycin Approved Phase 4,Phase 3,Phase 2 83905-01-5 55185 53477736 447043
32
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 2 564-25-0 54671203
33
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 83-43-2 6741
34
Prednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 50-24-8 5755
35
Cefdinir Approved Phase 4 91832-40-5 6915944
36
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3 50-28-2 5757
37
Ethinyl Estradiol Approved Phase 4,Phase 3 57-63-6 5991
38
Moxifloxacin Approved, Investigational Phase 4,Phase 3 354812-41-2, 151096-09-2 152946
39
Norgestimate Approved Phase 4,Phase 3 35189-28-7 6540478
40
Levofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2 100986-85-4 149096
41
Ofloxacin Approved Phase 4,Phase 3,Phase 2 82419-36-1 4583
42
Telithromycin Approved Phase 4,Phase 3 191114-48-4 5462516
43
Ethanol Approved Phase 4 64-17-5 702
44
Almotriptan Approved, Investigational Phase 4 154323-57-6, 181183-52-8 123606
45
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2 75614-87-8, 51-45-6 774
46
Omalizumab Approved, Investigational Phase 4,Phase 3,Phase 2 242138-07-4
47
Omeprazole Approved, Investigational, Vet_approved Phase 4 73590-58-6 4594
48
Antazoline Approved Phase 4 91-75-8 2200
49
Ipratropium Approved Phase 4 22254-24-6, 60205-81-4 43232
50
Magnesium Sulfate Approved, Vet_approved Phase 4 7487-88-9 24083

Interventional clinical trials:

(show top 50) (show all 711)

id Name Status NCT ID Phase Drugs
1 Middle Meatal Bacteriology During Acute Respiratory Infection in Children Unknown status NCT00545961 Phase 4 placebo;amoxicillin clavulanate acid
2 Study of Cefditoren Pivoxil in Treatment of Childhood With Acute Rhinosinusitis Unknown status NCT01553006 Phase 4 cefditoren pivoxil
3 Comparison of Daily Mometasone Furoate Nasal Spray Alone Versus a Combination With Montelukast for Treatment of Chronic Rhinosinusitis With Asthma After Functional Endoscopic Sinus Surgery Unknown status NCT02110654 Phase 4 Montelukast;mometasone furoate nasal spray
4 Comparision Between Hemodynamic Response of Dexmedetomidine and Remifentanil on Anesthesia in Endoscopic Sinus Surgery Unknown status NCT02464722 Phase 4 Dexmedetomidine;Remifentanil;Epinephrine;Propofol;Rocuronium
5 Remifentanil and Controlled Hypotension for Functional Endoscopic Sinus Surgery: Comparison With Tramadol and Metoprolol Unknown status NCT02484859 Phase 4 Remifentanil;Tramadol;Metoprolol
6 Safety and the Effects of Isolated Left Ventricular Pacing in Patients With Bradyarrhythmias Unknown status NCT01717469 Phase 4
7 Cardiac Resynchronization in Atrial Fibrillation Trial - a Pilot Study Unknown status NCT01850277 Phase 4 Amiodarone;Pharmacotherapy to slow and control ventricular rate
8 Evaluation of a Lateral Window Technique Augmentation for Maxillary Sinus Using Ultrasound Activated Pins Unknown status NCT02449707 Phase 4
9 Digoxin Versus Ivabradine in Heart Failure With Reduced Ejection Fraction Unknown status NCT02046044 Phase 4 Digoxin;Ivabradine
10 Use of Probiotics as Adjunctive Treatment for Chronic Rhinosinusitis Completed NCT00396162 Phase 4 probiotic containing L.rhamnosus R0011 strain
11 The Optimal Head Position for Distributing Topical Nasal Medication Using the Mucosal Atomization Device Completed NCT02079792 Phase 4
12 Treatment of Acute Sinusitis Completed NCT00377403 Phase 4 Acetaminophen;Amoxicillin;Dextromethorphan hydrobromide with guaifenesin;Guaifenesin;Pseudoephedrine Sustained Action;Saline spray (0.65%)
13 Sinuclean's Treatment Of Sinusitis' Symptoms Completed NCT00747747 Phase 4
14 Efficacy and Safety of Sinusitis Hevert SL Tablets Compared to Placebo in Adult Patients With Acute, Uncomplicated Rhinosinusitis Completed NCT02296814 Phase 4 Sinusitis Hevert SL Tablet;Placebo for Sinusitis Hevert SL Tablet
15 Study to Evaluate Safety and Effectiveness of AdvaCoat Sinus Gel Completed NCT00554190 Phase 4
16 The PIO II Study of In-office Placement of a Steroid-eluting Sinus Implant Completed NCT02668302 Phase 4
17 Comparison of Topical Vasoconstriction in Endoscopic Sinus Surgery Completed NCT01706952 Phase 4 Cocaine;Adrenaline
18 Hemostatic Matrix in Endoscopic Sinus Surgery Completed NCT00242437 Phase 4
19 Saline Irrigation After Surgery in Patients With Chronic Sinusitis Completed NCT01575223 Phase 4
20 Medicated Punctured-Glove-Finger Spacer Study Completed NCT01420471 Phase 4 Triamcinolone
21 Randomized Controlled Trial to Evaluate of Dexmedetomidine for the Effect on Operative Visibility in Patients Undergoing Endoscopic Sinus Surgery Completed NCT01569048 Phase 4 Propofol and dexmedetomidine;propofol and remifentanil
22 Duration of Antibiotic Therapy as Part of Maximal Medical Therapy for Chronic Rhinosinusitis Completed NCT01825408 Phase 4 Doxycycline;Azithromycin;Augmentin
23 Systemic Methylprednisolone in Chronic Rhinosinusitis Completed NCT01205984 Phase 4 methylprednisolone
24 Comparison Study Between Cefdinir & Amoxicilline/Clavulanate in Acute Sinusitis and Assessment of Quality of Life Completed NCT00147914 Phase 4 Cefdinir (drug);amoxicillin/clavulanate
25 Clinical Trial of the Treatment of Acute Sinusitis With Standard-dose Versus High-dose Amoxicillin/Clavulanate Completed NCT02340000 Phase 4 standard dose amoxicillin/clavulanate;high dose amoxicillin/clavulanate
26 Trial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With Avelox Completed NCT00668304 Phase 4 Avelox (Moxifloxacin, BAY12-8039)
27 Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment of Subjects With Acute Bacterial Sinusitis Completed NCT00645073 Phase 4 cefdinir (Omnicef);levofloxacin
28 Zmax Compared to Augmentin in Sinusitis Completed NCT00367120 Phase 4 Azithromycin Extended Release;Amoxicillin/Clavulanate
29 CHOOSE : Telithromycin, Acute Bacterial Sinusitis Completed NCT00174694 Phase 4 Telithromycin
30 Falls and Cardiovascular Events in Pacemaker Patients Completed NCT01037426 Phase 4
31 Evaluation of Histamine, CGRP and VIP as Markers for Activation of Trigeminal and Parasympathetic Nerve Fibers Completed NCT00208065 Phase 4 almotriptan or pseudoephedrine
32 The Impact Of The Addition Of Budesonide To Low-Pressure, High-Volume Saline Sinus Irrigation For Chronic Rhinosinusitis Completed NCT02696850 Phase 4 Budesonide;Saline alone
33 Prevention of Atrial Arrhythmia in Patients Without Atrioventricular (AV) Conduction Disease Completed NCT01170611 Phase 4
34 Xolair in Patients With Chronic Sinusitis Completed NCT00117611 Phase 4 Anti-IgE antibody omalizumab or placebo
35 Omeprazole 20 mg in Patients With Laryngopharyngeal reflux and Comorbid Chronic Rhinosinusitis Completed NCT03086070 Phase 4 Omeprazole 20mg;Placebo oral capsule
36 Study of Asthma and Nasal Steroids Completed NCT01118312 Phase 4 Mometasone Furoate monohydrate
37 Withdrawal Versus Continuation of Amiodarone in Successfully Treated Patients With Persistent Atrial Fibrillation Completed NCT00845780 Phase 4 withdrawal or continuation of amiodarone therapy
38 Spontaneous Atrio Ventricular Conduction Preservation Completed NCT00655213 Phase 4
39 Beluga - Clinical Observations of Automatic Algorithms for Cardiac Pacing Completed NCT00286858 Phase 4
40 Comparison Between 2 Bilateral Internal Thoracic Artery Coronary Artery Bypass Grafting Configurations Completed NCT01666366 Phase 4
41 DISCOVERY: Diagnostic Data and Genetic Polymorphisms in ICD Patients. Completed NCT00478933 Phase 4
42 Antazoline in Rapid Cardioversion of Paroxysmal Atrial Fibrillation Completed NCT01527279 Phase 4 antazoline;0.9% saline
43 Proteomic Profiling for Influenza Completed NCT00133588 Phase 4
44 Atrial Fibrillation Without Hemodynamic Instability in the Intensive Care Unit Completed NCT01461733 Phase 4 amiodarone;Placebo
45 The Effect of Packing in Post Operative Management of FESS Completed NCT00793117 Phase 4
46 Use of Fish Oils to Prevent Atrial Mechanical Stunning and Atrial Remodeling Due to Atrial Arrhythmia Completed NCT00232232 Phase 4 Fish oil
47 Single Dose Ultibro Breezhaler by Sd-DPI Versus Ipratropium/Salbutamol by Nebulizer in COPD Completed NCT02576626 Phase 4 indacaterol/glycopyrronium 110/50 Breezhaler®;ipratropium/salbutamol 0,5 mg, 2,5 mg by nebulisation
48 Controlled Hypotension During Functional Endoscopic Sinus Surgery Completed NCT01956981 Phase 4 Magnesium Sulfate;Dexmedetomidine
49 The Infected Bone Nonunion and Soft Tissue Defect of Long Bone Treated Simultaneously With Ilizarov Technique Completed NCT00846261 Phase 4
50 The Efficacy and Safety of Hyeonggaeyeongyo-tang for Chronic Rhinitis According to Pattern Identification in Korean Medicine Completed NCT02477293 Phase 4 Hyeonggaeyeongyo-tang

Search NIH Clinical Center for Paranasal Sinus Disease

Cochrane evidence based reviews: paranasal sinus diseases

Genetic Tests for Paranasal Sinus Disease

Anatomical Context for Paranasal Sinus Disease

MalaCards organs/tissues related to Paranasal Sinus Disease:

39
Heart, Bone, Eye, Lung, Kidney, Brain, Bone Marrow

Publications for Paranasal Sinus Disease

Articles related to Paranasal Sinus Disease:

(show all 49)
id Title Authors Year
1
Paranasal Sinus Disease in Children With Headache. ( 28831857 )
2017
2
Higher Body Mass Index and Increased Prevalence of Paranasal Sinus Disease. ( 26830349 )
2016
3
Pretransplant paranasal sinus disease is associated with a high incidence of transplant-related mortality in hematopoietic stem cell transplantation for children and adolescents. ( 27748554 )
2016
4
Association between diabetes and increased prevalence of paranasal sinus disease: a cross-sectional study in Japanese adults. ( 25728620 )
2015
5
A stereological study on the correlation of inferior turbinate hypertrophy and paranasal sinus disease. ( 24389985 )
2014
6
Headaches caused by nasal and paranasal sinus disease. ( 24703542 )
2014
7
Prognosis for sixth nerve palsy arising from paranasal sinus disease. ( 24119609 )
2013
8
The impact of a patient's age on the clinical presentation of inflammatory paranasal sinus disease. ( 23702318 )
2013
9
Equine paranasal sinus disease: a long-term study of 200 cases (1997-2009): ancillary diagnostic findings and involvement of the various sinus compartments. ( 21812807 )
2012
10
Equine paranasal sinus disease: a long-term study of 200 cases (1997-2009): treatments and long-term results of treatments. ( 21812808 )
2012
11
Clinical consensus statement: appropriate use of computed tomography for paranasal sinus disease. ( 23054429 )
2012
12
Ophthalmic manifestations of paranasal sinus disease: a clinical grading system. ( 22411699 )
2012
13
The expression of fibrinolytic components in chronic paranasal sinus disease. ( 21711960 )
2011
14
Paranasal sinus disease in horses. ( 21870345 )
2011
15
Complications of nose and paranasal sinus disease. ( 23272436 )
2011
16
Paranasal sinus disease and sputum eosinophilia in prednisone-dependent asthma. ( 21144367 )
2010
17
Thyroid Eye Disease and Paranasal Sinus Disease. ( 20924307 )
2010
18
T-cell regulation in chronic paranasal sinus disease. ( 18423831 )
2008
19
Significance of blood-tinged post-nasal drip in paranasal sinus disease. ( 17888198 )
2008
20
Headaches due to nasal and paranasal sinus disease. ( 15062525 )
2004
21
The incidence of concha bullosa and its relationship to nasal septal deviation and paranasal sinus disease. ( 15502150 )
2004
22
The role of leukotriene inhibitors in patients with paranasal sinus disease. ( 12923360 )
2003
23
CT characterization of inflammatory paranasal sinus disease in cystic fibrosis. ( 11972457 )
2002
24
Effect of irrigation of the nose with isotonic salt solution on adult patients with chronic paranasal sinus disease. ( 11195032 )
2000
25
Use of standard radiography to diagnose paranasal sinus disease of asthmatic children in Taiwan: comparison with computed tomography. ( 10466541 )
1999
26
Relative value of MR imaging as compared with CT in the diagnosis of inflammatory paranasal sinus disease. ( 9885603 )
1999
27
Optic nerve blindness due to paranasal sinus disease. ( 10420111 )
1999
28
[Cytokines and chemokines in paranasal sinus diseases]. ( 10535064 )
1999
29
Correlation of clinical examination with computer tomography in paranasal sinus disease. ( 9209590 )
1997
30
Imaging in paranasal sinus disease. ( 9619203 )
1997
31
Imaging of paranasal sinus disease. ( 9168874 )
1997
32
Malignant plasmacytoma appearing as invasive paranasal sinus disease after cardiac transplantation. ( 8883660 )
1996
33
Paranasal sinus disease in patients with cystic fibrosis. ( 8834282 )
1996
34
Efficacy of systemic corticosteroid treatment for anosmia with nasal and paranasal sinus disease. ( 8560170 )
1995
35
Nasal and paranasal sinus disease in patients with congenital velopharyngeal insufficiency. ( 8049050 )
1994
36
Inflammatory paranasal sinus disease in Bell's palsy demonstrated by magnetic resonance imaging. ( 8372929 )
1993
37
The prevalence of paranasal sinus disease in HIV infection and AIDS on cranial MR imaging. ( 8472478 )
1993
38
Effect of a topical vasoconstrictor on computed tomography of paranasal sinus disease. ( 8421421 )
1993
39
Endoscopic examination and treatment of paranasal sinus disease in 16 horses. ( 8116208 )
1993
40
Paranasal sinus disease in HIV antibody positive patients. ( 8335314 )
1993
41
Limited-slice CT in the evaluation of paranasal sinus disease in children. ( 1898816 )
1991
42
Paranasal sinus disease with intracranial extension: aspergillosis versus malignancy. ( 3131605 )
1988
43
Computed tomography in nasal and paranasal sinus disease. ( 6482629 )
1984
44
Comparison between transillumination and the roentgenogram in diagnosing paranasal sinus disease. ( 7451769 )
1981
45
Enzyme therapy in the triad of paranasal sinus disease, allergic asthmatic bronchitis, and bronchiectasis. ( 14446650 )
1959
46
The changing years: their impact upon the management of paranasal sinus disease. ( 13583895 )
1958
47
The changing years: their impact upon the management of paranasal sinus disease. ( 13647565 )
1958
48
Chronic paranasal sinus disease in adults; factors influencing treatment. ( 18124358 )
1949
49
Modern trends in diagnosis and treatment of paranasal sinus disease with particular reference to allergic manifestations. ( 20261616 )
1947

Variations for Paranasal Sinus Disease

Expression for Paranasal Sinus Disease

Search GEO for disease gene expression data for Paranasal Sinus Disease.

Pathways for Paranasal Sinus Disease

Pathways related to Paranasal Sinus Disease according to GeneCards Suite gene sharing:

(show all 45)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.98 ALOX5 CD79A GATA3 IFNG IL10 IL13
2
Show member pathways
13.63 ALOX5 IFNG IL10 IL13 IL17A IL4
3
Show member pathways
13.35 ALOX5 GATA3 IFNG IL10 IL13 IL17A
4
Show member pathways
13.28 FLNC IL10 IL13 IL17A IL4 IL5
5
Show member pathways
12.85 IFNG IL10 IL13 IL17A IL4 IL5
6
Show member pathways
12.59 ALOX5 CD79A IL13 IL4 IL5
7
Show member pathways
12.57 GATA3 IFNG IL10 IL13 IL17A IL4
8 12.55 ALOX5 CD79A GATA3 IFNG IL10 IL17A
9
Show member pathways
12.43 GATA3 IFNG IL10 IL17A IL4 IL5
10
Show member pathways
12.35 IFNG IL13 IL17A IL4 IL5 MUC5B
11
Show member pathways
12.29 ALOX5 IFNG IL10 IL4 TGFB1
12 12.28 FLNC PLAU PLAUR TGFB1
13
Show member pathways
12.23 IFNG IL10 IL13 IL4 IL5
14
Show member pathways
12.18 IFNG IL10 IL13 IL17A IL4 IL5
15 12.02 CD79A IFNG IL10 IL4 IL5
16 11.97 IFNG PLAU SERPINE1 TGFB1
17
Show member pathways
11.97 GATA3 IFNG IL10 IL17A TGFB1
18 11.95 IFNG IL4 TGFB1
19
Show member pathways
11.95 IFNG IL17A IL4 TGFB1
20 11.92 ALOX5 GATA3 IL10 IL13 IL17A IL4
21 11.85 IFNG IL10 TGFB1
22 11.84 GATA3 IFNG IL13 IL4 IL5
23 11.82 IFNG IL17A TGFB1
24 11.82 GATA3 IL10 IL5 SERPINE1
25
Show member pathways
11.8 GATA3 IFNG IL4 IL5
26 11.75 IL10 IL4 IL5 TGFB1
27 11.74 IFNG IL10 TGFB1
28 11.66 IL10 IL4 IL5
29 11.64 PLAU PLAUR SERPINE1
30 11.64 IL13 IL4 IL5 MUC5B PLAU TGFB1
31 11.61 IFNG SERPINE1 TGFB1
32 11.6 GATA3 IFNG IL10 IL13 IL17A IL4
33 11.53 IL10 IL13 IL4
34 11.53 IFNG IL10 TGFB1
35
Show member pathways
11.43 IFNG IL10 TGFB1
36 11.41 GATA3 IFNG IL10 IL13 IL4 IL5
37 11.35 IFNG IL4 IL5
38 11.27 IFNG IL13 TGFB1
39 11.24 IL10 IL13 IL17A IL4 IL5
40 11.22 IFNG IL10 IL13 IL4 IL5
41 11.13 GATA3 IL4 TGFB1
42 10.94 GATA3 IFNG IL13 IL17A IL4 IL5
43 10.93 IL13 IL4 IL5 TGFB1
44 10.89 PLAU PLAUR SERPINE1
45 10.58 IFNG IL10 IL13 IL4 IL5 TGFB1

GO Terms for Paranasal Sinus Disease

Cellular components related to Paranasal Sinus Disease according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.73 ALOX5 IFNG IL10 IL13 IL17A IL4
2 external side of plasma membrane GO:0009897 9.55 CD79A IFNG IL13 IL17A IL4
3 extracellular space GO:0005615 9.36 ALOX5 IFNG IL10 IL13 IL17A IL4

Biological processes related to Paranasal Sinus Disease according to GeneCards Suite gene sharing:

(show all 39)
id Name GO ID Score Top Affiliating Genes
1 positive regulation of transcription, DNA-templated GO:0045893 9.88 GATA3 IFNG IL10 IL4 IL5 TGFB1
2 positive regulation of protein phosphorylation GO:0001934 9.86 IFNG IL4 PLAUR TGFB1
3 response to ethanol GO:0045471 9.85 GATA3 IL13 IL4
4 positive regulation of sequence-specific DNA binding transcription factor activity GO:0051091 9.85